{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T19:10:29Z","timestamp":1758741029052,"version":"3.44.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:00:00Z","timestamp":1758672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"crossref","award":["PI22\/00009"],"award-info":[{"award-number":["PI22\/00009"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003196","name":"Italian Ministry of Health","doi-asserted-by":"crossref","award":["RF-2016-02361931"],"award-info":[{"award-number":["RF-2016-02361931"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trop Med Health"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Escalation in the use of biologic agents including tumor necrosis factor (TNF)-\u03b1 inhibitors to treat immune-mediated inflammatory diseases (IMID) is linked to higher susceptibility of severe infections caused by intracellular pathogens, including <jats:italic>Leishmania<\/jats:italic>.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This multicentric prospective study assessed the presence of <jats:italic>Leishmania<\/jats:italic> spp. infection among patients with IMID under treatment with biologic agents in two Italian clinical centers. We utilized a combination of diagnostic tests: real-time PCR for the detection of parasitic kinetoplast DNA in peripheral blood, Western blot for the identification of serum IgG antibodies, and a Whole blood assay to assess cytokine and chemokine responses following stimulation with parasitic antigen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 126 patients residing in Italy were enrolled. Patients testing positive in at least one assay were classified as <jats:italic>Leishmania<\/jats:italic>-positive. Of the 125 asymptomatic individuals, 25 (20%) tested positive for <jats:italic>Leishmania<\/jats:italic> infection, revealing a significant rate of subclinical infection. The most frequent marker of infection was positive serology (15\/126, 12%) followed by a detectable cell-mediated immune response (9\/125, 7%). Parasitic DNA was detected in 3 patients (2%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>This study showed a high prevalence of asymptomatic <jats:italic>Leishmania<\/jats:italic> infection in Italian patients with IMID under treatment with biologic agents, with a north-to-south gradient. Given the risk of disease reactivation, these patients may benefit from close monitoring. Further research is warranted to clarify the clinical implications of these findings.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s41182-025-00802-9","type":"journal-article","created":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:40:54Z","timestamp":1758739254000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Screening for Leishmania spp. infection in patients treated with biologic agents for immune-mediated inflammatory diseases: results of an Italian multicentric prospective study"],"prefix":"10.1186","volume":"53","author":[{"given":"Emma","family":"Balducelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara","family":"Morselli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Angheben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chiara","family":"Piubelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Perandin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Scarso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cinzia","family":"Scambi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Zammarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Barbiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Filippo","family":"Lagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Spinicci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Nacci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margherita","family":"Ortalli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simone","family":"Baiocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Javier","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Carrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefania","family":"Varani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,24]]},"reference":[{"issue":"10151","key":"802_CR1","first-page":"951","volume":"392","author":"S Burza","year":"2018","unstructured":"Burza S, Croft SL, Boelaert M. Leishmaniasis lancet. Scopus. 2018;392(10151):951\u201370.","journal-title":"Scopus"},{"issue":"5","key":"802_CR2","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006375","volume":"12","author":"H Akuffo","year":"2018","unstructured":"Akuffo H, Costa C, van Griensven J, Burza S, Moreno J, Herrero M. New insights into leishmaniasis in the immunosuppressed. PLoS Negl Trop Dis. 2018;12(5):e0006375.","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"802_CR3","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1111\/1469-0691.12556","volume":"20","author":"J van Griensven","year":"2014","unstructured":"van Griensven J, Carrillo E, L\u00f3pez-V\u00e9lez R, Lynen L, Moreno J. Leishmaniasis in immunosuppressed individuals. Clin Microbiol Infect. 2014;20(4):286\u201399.","journal-title":"Clin Microbiol Infect"},{"key":"802_CR4","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.3389\/fimmu.2018.01772","volume":"9","author":"K Arens","year":"2018","unstructured":"Arens K, Filippis C, Kleinfelder H, Goetzee A, Reichmann G, Crauwels P, et al. Anti-tumor necrosis factor \u03b1 therapeutics differentially affect Leishmania infection of human macrophages. Front Immunol. 2018;9:1772.","journal-title":"Front Immunol"},{"issue":"8","key":"802_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0007708","volume":"13","author":"P Bosch-Nicolau","year":"2019","unstructured":"Bosch-Nicolau P, Ubals M, Salvador F, S\u00e1nchez-Montalv\u00e1 A, Aparicio G, Erra A, et al. Leishmaniasis and tumor necrosis factor alpha antagonists in the Mediterranean basin. A switch in clinical expression. PLoS Negl Trop Dis. 2019;13(8):e0007708.","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"802_CR6","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.semarthrit.2013.01.006","volume":"43","author":"LS Guedes-Barbosa","year":"2013","unstructured":"Guedes-Barbosa LS, Pereira da Costa I, Fernandes V, Henrique da Mota LM, de Menezes I, Scheinberg MA. Leishmaniasis during anti-tumor necrosis factor therapy: report of 4 cases and review of the literature (additional 28 cases). Semin Arthritis Rheum. 2013;43(2):152\u20137.","journal-title":"Semin Arthritis Rheum"},{"key":"802_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ijid.2023.11.012","volume":"138","author":"A Deni","year":"2024","unstructured":"Deni A, De Pascali AM, Ortalli M, Balducelli E, Provenzano M, Ferrara F, et al. Identification of asymptomatic Leishmania infection in patients undergoing kidney transplant using multiple tests. Int J Infect Dis. 2024;138:81\u20133.","journal-title":"Int J Infect Dis"},{"issue":"8","key":"802_CR8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0009662","volume":"15","author":"L Botana","year":"2021","unstructured":"Botana L, Ibarra-Meneses AV, Sanchez C, Matia B, San Martin JV, Moreno J, et al. Leishmaniasis: a new method for confirming cure and detecting asymptomatic infection in patients receiving immunosuppressive treatment for autoimmune disease. PLoS Negl Trop Dis. 2021;15(8):e0009662.","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"802_CR9","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1093\/ecco-jcc\/jjab052","volume":"15","author":"T Kucharzik","year":"2021","unstructured":"Kucharzik T, Ellul P, Greuter T, Rahier JF, Verstockt B, Abreu C, et al. ECCO guidelines on the prevention, diagnosis, and management of infections in inflammatory bowel disease. J Crohns Colitis. 2021;15(6):879\u2013913.","journal-title":"J Crohns Colitis"},{"issue":"6","key":"802_CR10","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1136\/ard-2022-223335","volume":"82","author":"GE Fragoulis","year":"2023","unstructured":"Fragoulis GE, Nikiphorou E, Dey M, Zhao SS, Courvoisier DS, Arnaud L, et al. 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis. 2023;82(6):742\u201353.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"802_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13071-021-05129-y","volume":"15","author":"AV Ibarra-Meneses","year":"2022","unstructured":"Ibarra-Meneses AV, Corbeil A, Wagner V, Onwuchekwa C, Fernandez-Prada C. Identification of asymptomatic Leishmania infections: a scoping review. Parasit Vectors. 2022;15(1):5.","journal-title":"Parasit Vectors"},{"issue":"5","key":"802_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2020.e03940","volume":"6","author":"MC Guill\u00e9n","year":"2020","unstructured":"Guill\u00e9n MC, Alcover MM, Borruel N, Sulleiro E, Salvador F, Berenguer D, et al. Leishmania infantum asymptomatic infection in inflammatory bowel disease patients under anti-TNF therapy. Heliyon. 2020;6(5):e03940.","journal-title":"Heliyon"},{"issue":"4","key":"802_CR13","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/j.jinf.2022.01.029","volume":"84","author":"N Carrasco-Ant\u00f3n","year":"2022","unstructured":"Carrasco-Ant\u00f3n N, Ibarra-Meneses AV, Carrillo E, Fern\u00e1ndez-Ruiz M, Hern\u00e1ndez-Jim\u00e9nez P, Aguado JM, et al. An exploratory analysis of C-X-C motif chemokine ligand 10 as a new biomarker of asymptomatic Leishmania infantum infection in solid-organ transplant recipients. J Infect. 2022;84(4):573\u20138.","journal-title":"J Infect"},{"issue":"11","key":"802_CR14","doi-asserted-by":"publisher","first-page":"337","DOI":"10.3390\/tropicalmed7110337","volume":"7","author":"G Moirano","year":"2022","unstructured":"Moirano G, Ellena M, Mercogliano P, Richiardi L, Maule M. Spatio-temporal pattern and meteo-climatic determinants of visceral leishmaniasis in Italy. Trop Med Infect Dis. 2022;7(11):337.","journal-title":"Trop Med Infect Dis"}],"container-title":["Tropical Medicine and Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41182-025-00802-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41182-025-00802-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T18:40:56Z","timestamp":1758739256000},"score":1,"resource":{"primary":{"URL":"https:\/\/tropmedhealth.biomedcentral.com\/articles\/10.1186\/s41182-025-00802-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,24]]},"references-count":14,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["802"],"URL":"https:\/\/doi.org\/10.1186\/s41182-025-00802-9","relation":{},"ISSN":["1349-4147"],"issn-type":[{"value":"1349-4147","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,24]]},"assertion":[{"value":"1 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Ethics Committee of CE-AVEC on 18\/04\/2018 (study no. 144\/2018\/Sper\/AOUBO) and conducted in accordance with the principles of the Declaration of Helsinki on research in humans. All subjects agreed to participate by providing written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interest"}}],"article-number":"123"}}